Keyphrases
Confidence Interval
100%
Mini
100%
Fluticasone Propionate
100%
Nasal Spray
100%
Persistent Allergic Rhinitis
100%
Rhinoconjunctivitis Quality of Life Questionnaire
100%
Comparative Efficacy
100%
Comparative Safety
100%
Change from Baseline
66%
Test Formulation
66%
Steady State
33%
Plasma Concentration
33%
Placebo-controlled
33%
Urinary Cortisol
33%
Bioactivity
33%
Primary Outcome Measure
33%
Non-inferiority
33%
Peak Nasal Inspiratory Flow
33%
Washout Period
33%
Total Nasal Symptom Score
33%
Creatinine Ratio
33%
Nasal Corticosteroids
33%
Difference Test
33%
Clinical Equivalence
33%
Non-inferiority Design
33%
Pharmacology, Toxicology and Pharmaceutical Science
Fluticasone
100%
Nasal Spray
100%
Perennial Rhinitis
100%
Vasomotor Rhinitis
100%
Rhinoconjunctivitis
100%
Placebo
33%
Fluticasone Propionate
33%
Hydrocortisone
33%
Creatinine
33%